Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice
Reexamination Certificate
2007-05-01
2007-05-01
Tran, S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Cosmetic, antiperspirant, dentifrice
C424S440000, C424S451000, C424S464000, C514S152000
Reexamination Certificate
active
10117709
ABSTRACT:
A method of treating acne in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound.
REFERENCES:
patent: 4704383 (1987-11-01), McNamara et al.
patent: 5122519 (1992-06-01), Ritter
patent: 5157046 (1992-10-01), Van Wauwe et al.
patent: 5413777 (1995-05-01), Sheth et al.
patent: 5532227 (1996-07-01), Golub et al.
patent: 5674539 (1997-10-01), Tomas et al.
patent: 5827840 (1998-10-01), Ramamurthy et al.
patent: 5908838 (1999-06-01), Gans
patent: 5998390 (1999-12-01), Ramamurthy et al.
patent: 6664287 (2003-12-01), Avery et al.
patent: 6673843 (2004-01-01), Arbiser
patent: 7014858 (2006-03-01), Ashley
patent: 2003/0082120 (2003-05-01), Milstein
patent: 2003/0139380 (2003-07-01), Robert
patent: 0 410 099 (1991-01-01), None
patent: 02006437 (1990-01-01), None
patent: WO 83/00628 (1983-03-01), None
patent: WO 99/58131 (1999-11-01), None
Wong et al. “Oral ibuprofen and tetracycline for the treatment of acne vulgaris” (Journal of the American Academy of Dermatology), pp. 1076-1081; 1984.
Akamatsu et al. “Effect of Doxycycline on the Generation of Reactive Oxygen Species” (Stockh) 1992; 72:178-179.
Komman et al. “The Effect of Long-Term Low-Dose Tetracycline Therapy on the Subgingival Microflora in Refractory Adult Periodontitis” (J. Periodontol.) 53(10) 604-610; 1982.
Stedman's Medical Dictionary 27th Edition.
Webster et al., “Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory conentrations of tetracyclin and erythromycin”, British Journal of Dermatology (1981), pp. 453-457.
Plewig et al., “Acne:Morphogenesis and Treatment”, Spring-Verlag, pp. 297-301 (1975).
Webster et al., “Suppression of Polymorphonuclear Leukocyte Chemotactic Factor Production in Propionibacterium acnes by Subminimal Inhibitory Concentrations of Tetracycline, Ampicillin, Minocycline, and Erythromycin”, Antimicrobial Agents and Chemotherapy 21(5):770-772. 1982.
Kenneth S. Kornman and Edward H. Karl, “The Effect of Long-Term Low-Dose Tetracycline Therapy on the Subgingival Microflora in Refractory Adult Periodontitis,”J. Periodontol.53(10) 604-610 (Oct. 1982).
Akamatsu, et al. “Effect of Keigai-Rengyo-To, a Japanese Kampo Medicine, on Neutorphil Functions: a Possible Mechanism of Action of Keigai-Rengyo-To in Acne,”The Journal of International Medical Research, 25: 255-265 (1997).
Baer, et al. “High-Dose Tetracycline Therapy in Severe Acne,”Arch Dermatol, 112:479-481 (Apr. 1976).
Cheryl Guttman, “Emerging resistance changes face of antibiotic therapy for acne,”Dermatology Times, Jan. 2001, p. 22.
Hirohiko Akamatsu, Maki Asada, Jinro Komura, Yasuo Asada, and Yukie Niwa, “Effect of Doxycycline on the Generation of Reactive Oxygen Species: A Possible Mechanism of Action of Acne Therapy with Doxycycline,”Acta Derm Venereol(Stockh)72:178-178 (1992).
Bodokh, Y. Jacomet, J. Ph. Lacour and J.P. Ortonne, “Minocycline Induces an Increase in the Number of Excreting Pilosebaceous Follicles in Acne Vulgaris,”Acta Derm Venereol(Stockh),77:225-259 (1997).
W. J. Cunliffe, M.D., F.R.C.P., “Evolution of a Strategy for the Treatment of Acne,”J Am Acad Dermatol, 16:591-9 (1987).
E. Anne Eady, Eileen Ingham, Christina E. Walters, Jonathan H. Cove, and William J. Cunliffe, “Modulation of Comedonal Levels of Interleukin-1 in Acne Patients Treated with Tetracyclines,”J. Invest Dermatol, 101:86-91 (1993).
Boni E. Elewski, M.D., Beth A.J. Lamb, W. Mitchell Sams, Jr., M.D., and Ray Gammon, M.D., “In Vivo Suppression of Neutrophil Chemotaxis by Systemically and Topically Administered Tetracycline,”J Am Acad Dermatol, 8:807-812 (1983).
Nancy B. Esterly, M.D., Nancy L. Furey, M.D., and Lillian E. Flanagan, B.S., “The Effect of Antimicrobial Agents on Leukocyte Chemotaxis,”The Journal of Investigative Dermatology, 70(1):51-55 (1978).
Sainte-Marie, I. Tenaud, O. Jumbou and B. Dréno, “Minocycline Modulation of Alpha-MSH Production by Keratinocytes In vitro,”Acta Derm Venereol 79:265-267 (1999).
Hoshiki Miyachi, M.D., Akira Yoshioka, M.D., Sadao Imamura, M.D., and Yukie Niwa, M.D., “Effect of Antibiotics on the Generation of Reactive Oxygen Species,”J Invest Dermatol, 86(4):449-453 (1986).
Gerd Plewig, M.D., and Erwin Schöpf, M.D., “Anti-Inflammatory Effects of Antimicrobial Agents: An In Vivo Study,”The Journal of Investigative Dermatology, 65:532-536 (1975).
M. Toyoda and M. Morohashi, “An Overview of Topical Antibiotics for Acne Treatment,”Dermatology, 196:130-134 (1998).
Sheila E. Unkles, and Curtis G. Gemmell, “Effect of Clindamycin, Erythromycin, Lincomycin, and Tetracycline on Growth and Extracellular Lipase Production by Propionibacteria In Vitro,”Antimicrobial Agents and Chemotherapy, 21:39-43 (1982).
G.F. Webster, K.J. McGinley, and J.J. Leyden, “Inhibition of Lipase Production inPropionibacterium acnesby Sub-Minimal-Inhibitory Concentrations of Tetracycline and Erythromycin,”British Journal of Dermatology, 104:453-457 (1981).
Guy F. Webster, M.D., Ph.D., Susan M. Toso, M.S., and Lutz Hegemann, M.D., Ph.D., “Inhibition of a Model of In Vitro Granuloma Formation by Tetracyclines and Ciprofloxacin,”Arch Dermatol., 130:748-752 (1994).
Reynold C. Wong, M.D., Sewon Kang, M.P.H., Jan L. Heezen, L.P.N., John J. Voorhees, M.D., and Charles N. Ellis, M.D., “Oral Ibuprofen and Tetracycline for the Treatment of Acne Vulgaris,”J Am Acad Dermatol, 11:1076-1081 (1984).
Skidmore et al., “Effects of Subantimicrobial-Dose Doxycycline in the Treatment of Moderate Acne,”Archives of Dermatology139:459-464 (Apr. 2003), XP009047590.
Bikowski, J.B., “Treatment of rosacea with doxycycline monohydrate,” Curtis. 2000 Aug., 66(2):149-152.
Jimenez-Acosta, “Response to tetracycline of telangiectasias in male hemophiliac with human immunodeficiency virus infection,” J. Am. Acad. Dermatol. Aug. 1988, 19(2 Pt. 1):369-379.
Torresani, C., “Clarithromycin versus doxycycline in the treatment of rosacea,” Int. J. Clin. Dermatol. Dec. 1997, 36(12):942-946.
McClellan, K.J., “Topical Metronidazole. A rewiew of its use in rosaea,” Am. J. Clin. Dermatol. May-Jun. 2000, 1(3):191-199.
Quarterman, M.J., “Ocular Rosacea. Signs, symptoms and tear studies before and after treatment with doxycycline,” Arch. Dermatol. Jan. 1997, 133(1):49-54.
Akarnatsu, et al. “Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism,”Arch Dermatol Res 283: 524-528 (1991).
Bikowski, et al. “Treatment of rosacea with doxycycline monohydrate”Cutis, 66: 149-152 (Aug 2000).
Golub, et al. “Tetracyclines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs”Critical Reviews in Oral Biology and Medicine, 2(2): 297-322 (1991).
Illig “Positive side effects of antibiotic and antimicrobial substances in therapy”Infection 7(Suppl.6): S 584-588 (1979) (English translation. Original document in German.)
Knight, et al. “A follow-up of tetracycline-treated rosacea”British Journal of Dermatology 93: 577-580 (1975).
Marks, et al. “Comparative effectiveness of tetracycline and ampicillin in rosacea”The Lancet, 1049-1052 (Nov. 13, 1971).
Millar, et al. “A general practice study investigating the effect of minocycline (Minocine) 50 mg bd for 12 weeks in the treatment of acne vulgaris”The British Journal of Clinical Practice41(8):882-886 (Aug. 1987).
Plewig, et al.Acne: Morphogenesis and Treatment,Springer-Verlag 297-301 (1975).
Webster, et
CollaGenex Pharmaceuticals, Inc.
Hoffmann & Baron , LLP
Tran S.
LandOfFree
Methods of treating acne does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating acne, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating acne will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3760579